MAB Revenue and Competitors

Claim your profile




Total Funding

Real Estate


Estimated Revenue & Valuation

  • MAB's estimated annual revenue is currently $23.8M per year.(i)
  • MAB's estimated revenue per employee is $181,374

Employee Data

  • MAB has 131 Employees.(i)
  • MAB grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Established and owned by fifth generation Melbourne property identities, Michael and Andrew Buxton, MAB has activities in residential, retail, industrial and commercial developments, as well as a funds management business with approximately $150 million under management. With an unrivalled ability to deliver on complex planning outcomes for major projects and an established track record of creating outstanding public places; our people are committed to the vision of producing quality developments. By daring to imagine such visionary projects as NewQuay, Docklands and University Hill in Bundoora, MAB is playing a significant role in reshaping the environments in which we live, work and play. In a joint venture with Gibson Property Corporation (GPC), MAB has now embarked on its largest and most visionary development to date, Merrifield, a new city for Melbourne comprising more than 900 hectares located on the Hume Highway in Mickleham. We are building an enviable reputation for quality and establishing our business as one which thrives on challenge and opportunity. Mixed-Use Developments, Residential, Commercial, Business Parks, Masterplanned Communities, Funds Management



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





MAB News

2022-04-20 - Examining donor and antibody diversity with multiplex assays and flow cytometry

NK cell-related immunotherapeutics, such as tumor-specific monoclonal antibodies (mAbs) to elicit NK cell-mediated ADCC against tumor cells,...

2022-04-20 - Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

In a recent study published in the Science Immunology, researchers identified a human monoclonal antibody (mAb), 87G7, with in vitro...

2022-04-17 - I-Mab allegedly seeking asset or company sale - BioProcess ...

Shanghai-based I-Mab is in talks with global drugmakers about a potential sale of the whole company or its oncological assets, according to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding